BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 1,010,000 shares, a growth of 927.5% from the February 29th total of 98,300 shares. Based on an average daily trading volume, of 378,600 shares, the days-to-cover ratio […]
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) CEO Peter Altman acquired 108,108 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were acquired at an average cost of $0.46 per share, with a total value of $49,729.68. Following the transaction, the chief executive officer now owns 555,447 shares in […]
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) major shareholder Phillip Md Et Al Frost sold 129,802 shares of BioCardia stock in a transaction on Friday, January 19th. The stock was sold at an average price of $0.43, for a total transaction of $55,814.86. Following the completion of the transaction, the insider now owns 1,896,025 shares […]
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) major shareholder Phillip Md Et Al Frost sold 129,802 shares of BioCardia stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $0.43, for a total value of $55,814.86. Following the transaction, the insider now owns 1,896,025 shares of […]
BioCardia (NASDAQ:BCDA – Get Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Earnings and Valuation This table compares BioCardia and Vitro […]
BioCardia (NASDAQ:BCDA – Get Free Report) and Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings. Profitability This table compares BioCardia and Anavex […]
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totalling 27,300 shares, a decrease of 84.0% from the July 15th total of 171,000 shares. Based on an average trading volume of 101,600 shares, the […]
Alliance Global Partners lowered shares of BioCardia (NASDAQ:BCDA – Free Report) from a buy rating to a neutral rating in a research report released on Friday morning, FlyOnTheWall reports. Separately, HC Wainwright restated a buy rating and set a $9.00 price objective on shares of BioCardia in a research note on Monday, July 24th. BioCardia […]
Alliance Global Partners cut shares of BioCardia (NASDAQ:BCDA – Free Report) from a buy rating to a neutral rating in a research note issued to investors on Friday, FlyOnTheWall reports. Separately, HC Wainwright reissued a buy rating and issued a $9.00 target price on shares of BioCardia in a research report on Monday, July 24th. […]